ORBIT‐AMD: Ordinal Risk, Bilateral Imaging, and Trajectory Learning for Age‐Related Macular Degeneration in Multi‐Cohorts
Age-related macular degeneration (AMD) is an ordered, bilateral, and longitudinal disease, yet many artificial intelligence systems treat it as static binary image classification. We developed ORBIT-AMD, a multimodal trajectory-learning framework integrating color fundus photography and optical coherence tomography, bilateral eye-graph attention, concept bottlenecks, ordinal staging, cause-specific discrete-time survival prediction, and protocol alignment. In a UK Biobank development/internal-testing cohort of 58 214 participants and 109 691 eyes, and an external Tianjin Medical University Eye Hospital cohort of 1996 participants and 3780 eyes, ORBIT-AMD achieved AUROC values of 0.984 internally and 0.975 externally for prevalent late-AMD detection. Five-year late-AMD progression prediction achieved AUROC values of 0.825 and 0.767, respectively. Calibration and threshold analyses showed cohort-dependent workload and absolute-risk behavior, supporting site-specific calibration assessment and clinical-workflow evaluation before deployment. The concept bottleneck provided auditable lesion-level explanations, but these outputs should be interpreted as structured predictive explanations rather than causal evidence. ORBIT-AMD provides a trajectory-aware framework for AMD risk stratification and review prioritization, with prospective validation required before clinical implementation.
Authors
- Xiaorong Li (ORCID: https://orcid.org/0000-0002-2776-4225)
- Xuehao Cui (ORCID: https://orcid.org/0009-0002-6460-2783)
- Wen Dr
- Patrick Yu‐Wai‐Man
Institutions
- Tianjin University (CN)
- University of Cambridge (GB)
- Tianjin Medical University Eye Hospital (CN)
- Addenbrooke's Hospital (GB)
- Tianjin Medical University (CN)
- MRC Mitochondrial Biology Unit (GB)
Publication Details
- Journal
- Advanced Science
- Published
- 2026-06-27
- DOI
- https://doi.org/10.1002/advs.76361
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00